Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 17, Issue 1, Pages 207
Publisher
MDPI AG
Online
2019-12-28
DOI
10.3390/ijerph17010207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantifying Importance of Major Risk Factors for Coronary Heart Disease
- (2019) Michael J. Pencina et al. CIRCULATION
- The transferability of lipid loci across African, Asian and European cohorts
- (2019) Karoline Kuchenbaecker et al. Nature Communications
- Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
- (2019) Maria Mirabelli et al. Journal of Diabetes Research
- Cardiovascular disease risk prediction models: challenges and perspectives
- (2019) Farshad Farzadfar Lancet Global Health
- Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects
- (2018) O. Ramos-Lopez et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study
- (2018) Vera Frison et al. Diabetes Therapy
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Cardiovascular risk assessment in patients with diabetes
- (2017) Marcello Casaccia Bertoluci et al. Diabetology & Metabolic Syndrome
- Exposure-response analyses of liraglutide 3.0 mg for weight management
- (2016) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
- (2016) Eusebio Chiefari et al. Scientific Reports
- Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients
- (2015) Ping Feng et al. ACTA PHARMACOLOGICA SINICA
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
- (2015) Annunziata Lapolla et al. CLINICAL THERAPEUTICS
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
- (2015) Jessica E. Potts et al. PLoS One
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- The importance of weight management in type 2 diabetes mellitus
- (2014) J. P. H. Wilding INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Sex and gender influences on pharmacological response: an overview
- (2014) Flavia Franconi et al. Expert Review of Clinical Pharmacology
- A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
- (2013) Eusebio Chiefari et al. Scientific Reports
- Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
- (2013) Giuseppe Seghieri et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Medical Therapy for the Patient With Obesity
- (2012) George A. Bray et al. CIRCULATION
- An Overview of the Genetic Structure within the Italian Population from Genome-Wide Data
- (2012) Cornelia Di Gaetano et al. PLoS One
- Sex-Gender Differences in Diabetes Vascular Complications and Treatment
- (2012) Flavia Franconi et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Achieving a clinically relevant composite outcome of an HbA1c of
- (2011) B. Zinman et al. DIABETES OBESITY & METABOLISM
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
- (2010) M. Buysschaert et al. DIABETES & METABOLISM
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
- (2010) J. B. Buse et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- Common Variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 Genes as Predictors of Lipid-Lowering Response to Atorvastatin Therapy
- (2010) Aruna Poduri et al. DNA AND CELL BIOLOGY
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search